Sugi Predict

Sugi Predict / Compounds / SCHEMBL1774266

SCHEMBL1774266

SCHEMBL1774266

C[C@H]1COCc2nc3c(N)nc4cc(/C=C/C(=O)N(C)C)ccc4c3n21

nearest known ligand 0.38

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
▸ TLR7 Q9NYK1 2/20 0.38
▸ TLR8 Q9NR97 1/20 0.38
▸ IP6K1 Q92551 1/20 0.36
▸ IP6K2 Q9UHH9 1/20 0.36
▸ JAK3 P52333 2/20 0.33
▸ ABL1 P00519 11/20 0.33
▸ IDH1 O75874 1/20 0.33
▸ ESR1 P03372 1/20 0.33
▸ ESR2 Q92731 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1774269 1.00 TLR7 (0.38) TLR7TLR8IP6K1IP6K2JAK3
SCHEMBL1773905 0.85 TRPV1 (0.43) TLR7TLR8
SCHEMBL1773907 0.85 TRPV1 (0.43) TLR7TLR8
SCHEMBL1775932 0.79 TLR7 (0.41) TLR7TLR8ABL1
SCHEMBL1776284 0.79 TLR7 (0.40) TLR7TLR8JAK3ABL1IDH1
SCHEMBL1775391 0.77 TLR7 (0.41) TLR7TLR8ABL1
SCHEMBL10237186 0.74 TLR7 (0.44) TLR7TLR8
SCHEMBL1773813 0.74 TLR7 (0.44) TLR7TLR8
SCHEMBL1775022 0.73 ABL1 (0.34) TLR7ABL1
SCHEMBL1774924 0.73 TLR7 (0.34) TLR7TLR8ABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8546383-B2 Chiral fused [1,2]imidazo[4,5-c] ring compounds 3M INNOVATIVE PROPERTIES COMPANY (US) 2013-10-01 — — US disclosed
US-20120232057-A1 CHIRAL FUSED [1,2]IMIDAZO[4,5-c] RING COMPOUNDS 3M INNOVATIVE PROPERTIES COMPANY 2012-09-13 — — US disclosed
EP-1831226-B1 CHIRAL TETRACYCLIC COMPOUNDS INDUCING INTERFERON BIOSYNTHESIS 3M INNOVATIVE PROPERTIES CO (US) 2012-08-08 — — EP disclosed
US-8207162-B2 Chiral fused [1,2]imidazo[4,5-c] ring compounds 3M INNOVATIVE PROPERTIES COMPANY (US) 2012-06-26 — — US disclosed
US-20110207725-A1 CHIRAL FUSED [1,2]IMIDAZO[4,5-c] RING COMPOUNDS 3M INNOVATIVE PROPERTIES COMPANY 2011-08-25 — — US disclosed
US-7943609-B2 Such as (tetrahydr)imidazo(4,5-c ) quinoline or naphthymidine; immunomoderators; induce cytokine biosynthesis in animals; anticancer agents; viricides 3M INNOVATIVE PROPRERTIES COMPANY (US) 2011-05-17 — — US disclosed
US-20080269192-A1 Chiral Fused [1,2]Imidazo[4,5-C] Ring Compounds COLEY PHARMACEUTICAL GROUP, INC. (US) 2008-10-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080269192-A1 Chiral Fused [1,2]Imidazo[4,5-C] Ring Compounds IFNAR1, IFNG, IL4 TLR7 124/4885TLR8 409/4885IP6K1 1412/4885
US-20120232057-A1 CHIRAL FUSED [1,2]IMIDAZO[4,5-c] RING COMPOUNDS IFNAR1, IFNG, IL4 TLR7 132/4885TLR8 440/4885IP6K1 1398/4885
US-20110207725-A1 CHIRAL FUSED [1,2]IMIDAZO[4,5-c] RING COMPOUNDS IFNAR1, IFNG, IL4 TLR7 124/4885TLR8 409/4885IP6K1 1412/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.